Anthony Petrone Analyst Performance

Managing Director Equity Research at Mizuho

Anthony Petrone is a stock analyst at Mizuho in the medical sector, covering 26 publicly traded companies. Over the past year, Anthony Petrone has issued 33 stock ratings, including buy and hold recommendations. While full access to Anthony Petrone's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Anthony Petrone's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

51 Last 10 Years

Buy Recommendations

82.61% 38 Buy Ratings

Companies Covered

26 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	82.6%	38 ratings
Hold	17.4%	8 ratings
Sell	0.0%	0 ratings

Out of 46 total stock ratings issued by Anthony Petrone at Mizuho, the majority (82.6%) have been Buy recommendations, followed by 17.4% Hold.

Best & Worst Calls

• Best Call

  0000.0%

  ATRS

  May 2016

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  MNK

  May 2015

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	61.5% of companies on NASDAQ	16 companies
NYSE	38.5% of companies on NYSE	10 companies

Anthony Petrone, an analyst at Mizuho, currently covers 26 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 26 companies	100.0%

Anthony Petrone of Mizuho specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED INSTRUMENTS 9 companies	34.6%
MED PRODUCTS 6 companies	23.1%
MED - BIOMED/GENE 4 companies	15.4%
MEDICAL SERVICES 2 companies	7.7%
MED/DENTAL - SUPP 2 companies	7.7%
PROCESS CONTROL INSTRUMENTS 1 company	3.8%
PHARMACEUTICAL PREPARATIONS 1 company	3.8%
SURGICAL & MEDICAL INSTRUMENTS 1 company	3.8%

Anthony Petrone's Ratings History at Mizuho

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
GH Guardant Health	9/25/2025	Boost Price Target	$61.55	$70.00	Outperform	$0.00 00.00% ROI
ALC Alcon	8/21/2025	Lower Price Target	$79.26	$110.00	Outperform	$0.00 00.00% ROI
HAE Haemonetics	8/8/2025	Lower Price Target	$55.49	$70.00	Outperform	$0.00 00.00% ROI
LNTH Lantheus	8/7/2025	Lower Price Target	$51.87	$70.00	Outperform	$0.00 00.00% ROI
RMD ResMed	8/1/2025	Boost Price Target	$279.57	$290.00	Outperform	$0.00 00.00% ROI
TFX Teleflex	8/1/2025	Boost Price Target	$114.60	$135.00	Neutral	$0.00 00.00% ROI
HOLX Hologic	7/31/2025	Set Price Target	$67.25	$75.00		$0.00 00.00% ROI
EW Edwards Lifesciences	7/25/2025	Boost Price Target	$78.75	$95.00	Outperform	$0.00 00.00% ROI
EW Edwards Lifesciences	7/16/2025	Boost Price Target	$76.90	$87.00	Outperform	$0.00 00.00% ROI
DXCM DexCom	7/16/2025	Boost Price Target	$84.78	$100.00	Outperform	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ABT Abbott Laboratories	7/16/2025	Boost Price Target	$131.41	$140.00	Neutral	$0.00 00.00% ROI
RMD ResMed	7/16/2025	Boost Price Target	$251.98	$270.00	Outperform	$0.00 00.00% ROI
MDT Medtronic	7/16/2025	Boost Price Target	$89.26	$100.00	Outperform	$0.00 00.00% ROI
HOLX Hologic	7/16/2025	Boost Price Target	$63.26	$70.00	Outperform	$0.00 00.00% ROI
ESTA Establishment Labs	7/16/2025	Boost Price Target	$44.42	$70.00	Outperform	$0.00 00.00% ROI
EMBC Embecta	7/16/2025	Lower Price Target	$9.58	$12.00	Neutral	$0.00 00.00% ROI
COO Cooper Companies	7/16/2025	Lower Price Target	$72.20	$90.00	Outperform	$0.00 00.00% ROI
TFX Teleflex	7/16/2025	Lower Price Target	$113.50	$130.00	Neutral	$0.00 00.00% ROI
STAA STAAR Surgical	7/16/2025	Boost Price Target	$16.86	$18.00	Neutral	$0.00 00.00% ROI
MDT Medtronic	5/22/2025	Lower Price Target	$81.67	$98.00	Outperform	$0.00 00.00% ROI
TFX Teleflex	4/16/2025	Set Price Target	$128.22	$155.00		$0.00 00.00% ROI
RMD ResMed	4/16/2025	Set Price Target	$211.79	$265.00		$0.00 00.00% ROI
EMBC Embecta	4/10/2025	Initiated Coverage	$12.65	$15.00	Neutral	$0.00 00.00% ROI
GH Guardant Health	4/10/2025	Initiated Coverage	$43.87	$55.00	Outperform	$0.00 00.00% ROI
SENS Senseonics	4/10/2025	Initiated Coverage	$0.60	$2.00	Outperform	$0.00 00.00% ROI
TNDM Tandem Diabetes Care	4/10/2025	Initiated Coverage	$17.61	$20.00	Neutral	$0.00 00.00% ROI
DXCM DexCom	4/10/2025	Initiated Coverage	$66.84	$85.00	Outperform	$0.00 00.00% ROI
EXAS Exact Sciences	4/10/2025	Initiated Coverage	$45.50	$60.00	Outperform	$0.00 00.00% ROI
ALC Alcon	3/28/2025	Boost Price Target	$96.95	$120.00	Outperform	$0.00 00.00% ROI
TARS Tarsus Pharmaceuticals	3/6/2025	Boost Price Target	$43.57	$58.00	Buy	$0.00 00.00% ROI
LIVN LivaNova	2/26/2025	Lower Price Target	$41.16	$60.00	Outperform	$0.00 00.00% ROI
GKOS Glaukos	2/19/2025	Upgrade	$153.00	$200.00	Outperform	$0.00 00.00% ROI
ISRG Intuitive Surgical	10/17/2024	Boost Price Target	$474.85	$500.00		$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.